Format

Send to

Choose Destination
See comment in PubMed Commons below
Neurosci Biobehav Rev. 2013 Jun;37(5):753-65. doi: 10.1016/j.neubiorev.2013.03.009. Epub 2013 Mar 21.

Meta-analysis of functional network alterations in Alzheimer's disease: toward a network biomarker.

Author information

  • 1Cognitive Neuroscience, Institute of Neuroscience and Medicine-3, Research Centre Jülich, Jülich, Germany. h.jacobs@fz-juelich.de

Abstract

The increasing prevalence of Alzheimer's disease (AD) emphasizes the need for sensitive biomarkers. Memory, a core deficit in AD, involves the interaction of distributed brain networks. We propose that biomarkers should be sought at the level of disease-specific disturbances in large-scale neural networks instead of alterations in a single brain region. This is the first voxel-level quantitative meta-analysis of default mode connectivity and task-related activation in 1196 patients and 1255 controls to detect robust changes in components of large-scale neural networks. We show that with disease progression, specific components of networks are widespread altered. The medial parietal regions and the subcortical areas are differentially affected depending on the disease stage. Specific compensatory mechanisms are only seen in the earliest stages, before symptoms are evident, and could become a functional network biomarker or target for interventions. These results underline the need to further fine-grain these networks spatially and temporally across disease stages. To conclude, AD should indeed be considered as a syndrome involving neural network disruption before cognitive deficits are detectable.

PMID:
23523750
DOI:
10.1016/j.neubiorev.2013.03.009
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center